Smar NetworkSmar.inSmargrid.comNewsInsuranceRoomsGamesMeasurements

Insurance Daily News

Daily news and analysis on insurance industry trends, regulations, and market insights

Facebook Telegram
← Back to Insurance News

Supreme Court Reviews Terror Funding Suit Against Drugmakers

📅 2026-11-10 | 📰 Claims Journal
#supreme court #terror financing #pharmaceutical liability #anti-terrorism act #iraq

The U.S. Supreme Court has requested the Trump administration’s response to an appeal filed by several pharmaceutical and medical-device companies seeking to block a lawsuit that accuses them of financing terrorist attacks in Iraq. The suit alleges that the companies paid millions in bribes to secure medical-supply contracts with the Iraqi Ministry of Health between 2004 and 2013, money that allegedly went to the militant group Jaysh al-Mahdi, which controlled the ministry at the time.

Defendants include units of AstraZeneca Plc, Roche Holding Ltd., GE HealthCare Technologies Inc., Johnson & Johnson, Pfizer Inc. and Viatris Inc. The plaintiffs—U.S. servicemembers, civilians who served in Iraq, and their families—argue that the companies knowingly funded the group’s attacks. The companies contend they acted at the encouragement of the U.S. government and that the complaint does not establish a sufficiently close link between their transactions and specific terrorist acts, nor the intent required under the U.S. Anti-Terrorism Act.

A federal appeals court in Washington previously allowed the case to proceed, finding the complaint adequately alleged that the companies repeatedly structured transactions in an unusual and illegal manner that facilitated Jaysh al-Mahdi’s activities. The Supreme Court’s request for the Solicitor General’s brief signals that the justices will consider whether the Anti-Terrorism Act can be applied to corporate conduct in this context.

Why it matters

Insurance carriers must monitor potential liability exposure from anti-terrorism statutes as courts interpret their reach over corporate conduct.

FAQ

Which companies are named as defendants in the lawsuit?
Units of AstraZeneca Plc, Roche Holding Ltd., GE HealthCare Technologies Inc., Johnson & Johnson, Pfizer Inc. and Viatris Inc.

What time period do the alleged bribes cover?
The alleged bribes were paid to secure contracts with the Iraqi Ministry of Health from 2004 to 2013.

What legal act is at the center of the dispute?
The U.S. Anti-Terrorism Act.

Which militant group is alleged to have received the bribe money?
Jaysh al-Mahdi.

Source: Claims Journal. See the original source for full details.